Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection.

Source:http://linkedlifedata.com/resource/pubmed/id/12072488

Download in:

View as

General Info

PMID
12072488